alanyl-glutamyl-aspartyl-glycine has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alimova, IN; Anisimov, VN; Baturin, DA; Franceschi, C; Imyanitov, EN; Khavinson, VK; Mancini, R; Popovich, IG; Provinciali, M; Zabezhinski, MA | 1 |
| Alimova, IN; Anisimov, VN; Francheski, K; Khavinsov, VKh; Manchini, R; Provintsiali, M | 1 |
2 other study(ies) available for alanyl-glutamyl-aspartyl-glycine and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Topics: Animals; Body Weight; Cell Division; Dipeptides; Feeding Behavior; Female; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Oligopeptides; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2002 |
Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging.
Topics: Adenocarcinoma; Aging; Animals; Antineoplastic Agents; Dipeptides; Female; Gene Expression; Genes, erbB-2; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Oligopeptides; Random Allocation; RNA, Messenger | 2002 |